Rosuvastatin 10 mg
Sponsors
GlaxoSmithKline, D16 Pharma & Biotec Ltd., Chong Kun Dang Pharmaceutical, Rania Mahmoud Mohamed
Conditions
AsthmaAtherosclerosisBioequivalenceCrohn's DiseaseDyslipidemiaDyslipidemias
Phase 1
A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin
CompletedNCT01411111
Start: 2011-01-06End: 2011-02-23Updated: 2017-07-25
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
CompletedNCT01489943
Start: 2011-09-19End: 2011-11-10Updated: 2017-07-25
To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
CompletedNCT01751074
Start: 2012-12-17End: 2013-03-14Updated: 2017-07-26
Bioequivalence Study of Rosuvastatin in Healthy Volunteers Under Fasting Condition
CompletedNCT05197517
Start: 2020-09-21End: 2020-10-01Updated: 2022-01-20